Lu JJ, Xing H, Wang CH, Tang MJ, Wu CC, Ye F, Yin LJ, Yang Y, Tan WJ, Shen L. Mpox (formerly monkeypox): pathogenesis, prevention, and treatment. Signal Transduct Tar 2023, 8(1).

Cevik M, Tomori O, Mbala P, Scagliarini A, Petersen E, Low N, Heymann D, Lee SS, Blumberg L. The 2023–2024 multi-source mpox outbreaks of Clade I MPXV in sub-saharan Africa: alarm bell for Africa and the World. Int J Infect Dis 2024, 146.

Rizzo A, Giacomelli A, Moschese D, Mileto D. Re-emergence of Mpox associated with a distinct MPXV clade: implications for public health and stigma mitigation. Infect Dis-Nor 2024.

Yang ZL. Monkeypox: a potential global threat? J Med Virol. 2022;94(9):4034–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tian YX, Li MJ, Yang Y, Li CH, Peng Y, Yang HY, Zhao MY, Wu PF, Ruan SB, Huang YY et al. An MPXV mRNA-LNP vaccine candidate elicits protective immune responses against monkeypox virus. Chin Chem Lett 2024, 35(8).

P E F ZJ, B G. H D: The transmission potential of monkeypox virus in human populations. Int J Epidemiol 1988, 17(3).

Katy B, Peter AL. Human monkeypox: current state of knowledge and implications for the future. J Trop Med Infect Dis 2016, 1(1).

Yang L, Chen YS, Li S, Zhou Y, Zhang YL, Pei RJ, Chen XW, Wang Y. Immunization of mice with Vaccinia virus Tiantan strain yields antibodies cross-reactive with protective antigens of monkeypox virus. Virol Sin. 2023;38(1):162–4.

Article  CAS  PubMed  Google Scholar 

Zhen ZD, Zhang LL, Li Q, Zhu Y, Wang XH, Fu XY, Ai JH, Wang R, Xie ZD, Ma SX. Cross-reactive antibodies against monkeypox virus exist in the population immunized with Vaccinia Tian Tan strain in China. Infect Genet Evol 2023, 113.

Lu B, Cui LB, Gu MH, Shi C, Sun CW, Zhao KC, Bi J, Tan ZM, Guo XL, Huo X, et al. Outbreak of Vaccinia Virus infection from Occupational exposure, China, 2017. Emerg Infect Dis. 2019;25(6):1192–5.

Article  PubMed  PubMed Central  Google Scholar 

Marriott KA, Parkinson CV, Morefield SI, Davenport R, Nichols R, Monath TP. Clonal vaccinia virus grown in cell culture fully protects monkeys from lethal monkeypox challenge. Vaccine. 2008;26(4):581–8.

Article  CAS  PubMed  Google Scholar 

Artenstein AW, Johnson C, Marbury TC, Morrison D, Blum PS, Kemp T, Nichols R, Balser JP, Currie M, Monath TP. A novel, cell culture-derived smallpox vaccine in vaccinia-naive adults. Vaccine. 2005;23(25):3301–9.

Article  CAS  PubMed  Google Scholar 

Osborne JD, Da Silva M, Frace AM, Sammons SA, Olsen-Rasmussen M, Upton C, Buller RML, Chen NC, Feng ZH, Roper RL et al. Genomic differences of clones from Dryvax smallpox vaccine: The Dryvax-like ACAM2000 and the mouse neurovirulent Clone-3. Vaccine 2007, 25(52):8807–8832.

Li YQ, Sheng Y, Chu YJ, Ji HF, Jiang S, Lan T, Li M, Chen S, Fan YY, Li WJ, et al. Seven major genomic deletions of Vaccinia virus Tiantan strain are sufficient to decrease pathogenicity. Antivir Res. 2016;129:1–12.

Article  PubMed  Google Scholar 

Li YQ, Zhu YL, Chen S, Li WJ, Yin XZ, Li SZ, Xiao PP, Han JC, Li X, Sun LL et al. Generation of an attenuated Tiantan Vaccinia Virus strain by deletion of multiple genes. Front Cell Infect Mi 2017, 7.

Reed LJM. A simple method of estimating 50% endpoints. Am J Hyg. 1938;27:493–7.

Google Scholar 

Li Y, Yang X, Han JC, Bai B, Li YR, Shang C, Li SZ, Xiu ZR, Liu ZR, Ge CC, et al. Peimisine ameliorates DSS-induced colitis by suppressing Jak-Stat activation and alleviating gut microbiota dysbiosis in mice. J Pharm Pharmacol. 2024;76(5):545–58.

Article  PubMed  Google Scholar 

Matute-Bello G, Downey G, Moore B, Groshong S, Matthay M, Slutsky A, Kuebler W. JAjorc, biology m: an official American thoracic society workshop report: features and measurements of experimental acute lung injury in animals. 2011, 44(5):725–38.

Kulkarni H, Lee J, Bastarache J, Kuebler W, Downey G, Albaiceta G, Altemeier W, Artigas A, Bates J, Calfee C et al. Update on the features and measurements of experimental Acute Lung Injury in animals: an official American thoracic Society Workshop Report. 2022, 66(2):e1–14.

Finn CM, Prokop E, Dhume K, McKinstry K. STAT1 expression controls CD4 T cell Th1 and Th17 effector functionality during influenza virus infection. J Immunol 2023, 210(1).

Horwitz M, Allanach J. Epstein-Barr Virus infection of B cells promotes Th1-mediated disease in multiple sclerosis. Mult Scler J. 2023;29:10–10.

Google Scholar 

Greigert H, Ramon A, Genet C, Cladière C, Gerard C, Cuidad M, Corbera-Bellalta M, Alba-Rovira R, Arnould L, Creuzot-Garcher C et al. Neointimal myofibroblasts contribute to maintaining Th1/Tc1 and Th17/ Tc17 inflammation in giant cell arteritis. J Autoimmun 2024, 142.

Bangert C, Rindler K, Krausgruber T, Alkon N, Thaler F, Ayub T, Vorstandlechner V, Bauer WM, Mildner M, Elbe-Buerger A, et al. Persistence of mature dendritic cells, Th2A and Tc2 cells characterize clinically resolved atopic dermatitis under IL-4R-alpha blockade. J Invest Dermatol. 2021;141(5):S115–115.

Article  Google Scholar 

van Den Broek M, Bachmann M, Köhler G, Barner M, Escher R, Zinkernagel R, Kopf M. IL-4 and IL-10 antagonize IL-12-mediated protection against acute vaccinia virus infection with a limited role of IFN-gamma and nitric oxide synthetase 2. J Immunol. 2000;164(1):371–8.

Article  PubMed  Google Scholar 

Parjapati V, Verma VK, Bhatia J, Arya DS. Therapeutic potential of Abatacept in Rat Model of Cardiac Hypertrophy Via Lidding Cd80 and Cd86: a Profound Exploration of Signaling pathways. J Hypertens 2024, 42.

Verma VK, Mutneja E, Bhatia J, Arya DS. Cd80 and Cd86 masking on Antigen-presenting cells exhibited Protection from Myocardial Necrosis and Ischemia-Reperfusion Injury: a preclinical validation. J Hypertens 2024, 42.

Logunova N, Kapina M, Dyatlov A, Kondratieva T, Rubakova E, Majorov K, Kondratieva E, Linge I, Apt A. Polygenic TB control and the sequence of innate/adaptive immune responses to infection: MHC-II alleles determine the size of the S100A8/9-producing neutrophil population. Immunology 2024.

Romero-Castillo L, Li TT, Do NN, Sareila O, Xu BZ, Hennings V, Xu ZW, Svensson C, Oliveira-Coelho A, Sener Z et al. Human MHC Class II and Invariant Chain Knock-in Mice Mimic Rheumatoid Arthritis with Allele Restriction in Immune Response and Arthritis Association. Adv Sci 2024, 11(23).

Tian SM, Wang YF, Wan J, Yang M, Fu ZK. Co-stimulators CD40-CD40L, a potential immune-therapy target for atherosclerosis: a review. Medicine 2024, 103(14).

Strohm L, Daiber A, Ubbens H, Krishnankutty R, Oelze M, Kuntic M, Hahad O, Klein V, Hoefer IE, von Kriegsheim A et al. Role of inflammatory signaling pathways involving the CD40-CD40L-TRAF cascade in diabetes and hypertension-insights from animal and human studies. Basic Res Cardiol 2024.

Zhang NB, Cheng X, Zhu YL, Mo OY, Yu HQ, Zhu LQ, Zhang J, Kuang LL, Gao Y, Cao RY, et al. Multi-valent mRNA vaccines against monkeypox enveloped or mature viron surface antigens demonstrate robust immune response and neutralizing activity. Sci China Life Sci. 2023;66(10):2329–41.

Article  CAS  PubMed  Google Scholar 

Zhang RR, Wang ZJ, Zhu YL, Tang W, Zhou C, Zhao SQ, Wu M, Ming T, Deng YQ, Chen Q et al. Rational development of multicomponent mRNA vaccine candidates against mpox. Emerg Microbes Infec 2023, 12(1).

Alhalaseh Y, Modi MB, Haddad S, Souchik A, Speiser JJ, Massarani-Wafai R, Dahiya M. Mpox Case presenting with genital lesions and Proctitis. Am J Dermatopath. 2024;46(4):243–6.

Article  PubMed  Google Scholar 

Vashistha MP, Shreya VP. Epidemiol Rev Monkeypox Cureus 2023, 15(2).

Valli MB, Vulcano A, Rueca M, Matusali G, Mazzotta V, Nicastri E, Girardi E, Fontana C, Antinori A, Maggi F. Concomitant syndromic diagnosis of Mpox and other vesicular viruses in patients with skin and genital lesions. Pathogens 2024, 13(3).

Li ET, Guo XP, Hong DX, Gong QZ, Xie WY, Li TT, Wang J, Chuai X, Chiu S. Duration of humoral immunity from smallpox vaccination and its cross-reaction with Mpox virus. Signal Transduct Tar 2023, 8(1).

Li M, Guo YX, Deng Y, Gao WH, Huang BY, Yao WY, Zhao YZ, Zhang Q, Huang MK, Liu MS et al. Long-lasting humoral and cellular memory immunity to Vaccinia virus Tiantan provides pre-existing immunity against mpox virus in Chinese population. Cell Rep 2024, 43(1).

Tartaglia J, Perkus ME, Taylor J, Norton EK, Audonnet JC, Cox WI, Davis SW, van der Hoeven J, Meignier B, Riviere M. NYVAC: a highly attenuated strain of Vaccinia virus. J Virol. 1992;188(1):217–32.

Article  CAS  Google Scholar 

Guerra S, Abaitua F, Martínez-Sobrido L, Esteban M, García-Sastre A, Rodríguez D. Host-range restriction of Vaccinia virus E3L deletion mutant can be overcome in vitro, but not in vivo, by expression of the influenza virus NS1 protein. PLoS ONE. 2011;6(12):e28677.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brennan G, Kitzman JO, Shendure J, Geballe AP. Experimental evolution identifies Vaccinia Virus mutations in A24R and A35R that antagonize the Protein Kinase R Pathway and accompany collapse of an extragenic gene amplification. J Virol. 2015;89(19):9986–97.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Legrand FA, Verardi PH, Chan KS, Peng Y, Jones LA, Yilma TD. Vaccinia viruses with a serpin gene deletion and expressing IFN-γ induce potent immune responses without detectable replication. P Natl Acad Sci USA. 2005;102(8):2940–5.

Article  CAS  Google Scholar 

Chen RAJ, Jacobs N, Smith GL. Vaccinia virus strain Western Reserve protein B14 is an intracellular virulence factor. J Gen Virol. 2006;87:1451–8.

Article  CAS  PubMed  Google Scholar 

Child S, Palumbo G, Buller R, Hruby D. Insertional inactivation of the large subunit of ribonucleotide reductase encoded by Vaccinia virus is associated with reduced virulence in vivo. J Virol. 1990;174(2):625–9.

Article  CAS  Google Scholar 

Li YQ, Chen S, Fang JB, Zhu YL, Bai B, Li WJ, Yin XZ, Wang J, Liu X, Han JC, et al. Construction of an attenuated tian Tan Vaccinia virus strain by deletion of TA35R and TJ2R genes. Virus Res. 2018;256:192–200.

Article  CAS  PubMed  Google Scholar